John T Barberia

Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.

Dennis E Danley, P. Lemotte, M. Mansour, 2005, Journal of medicinal chemistry.

Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors.

Dennis E Danley, D. Danley, G. Schulte, 2002, Bioorganic & medicinal chemistry letters.

Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.

I. Otterness, T. Carty, J. Liras, 2005, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.

F. Lombardo, A. Kalgutkar, E. Laird, 2006, Bioorganic & medicinal chemistry letters.

Benzimidazolone p38 inhibitors.

C. Gabel, T. Carty, John T Barberia, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.

Chul Yu, Mark C. Noe, Lisa M. Reeves, 2003, Bioorganic & medicinal chemistry letters.

IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin.

C. Gabel, K. Geoghegan, A. Lanzetti, 1992, Journal of immunology.

Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.

I. Otterness, T. Carty, J. Liras, 2005, Bioorganic & medicinal chemistry letters.